Discontinued — last reported Q4 '20

Other Income & Expense

Finance Lease Interest

Vertex Pharmaceuticals Finance Lease Interest remained flat by 0.0% to $1.43M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 77.4%, from $6.30M to $1.43M. Over 2 years (FY 2023 to FY 2025), Finance Lease Interest shows a downward trend with a -61.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementIncome Statement
SectionOther Income & Expense
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ1 2019
Last reportedQ4 2020

How to read this metric

An increase in this expense reflects higher financing costs or a larger portfolio of finance leases.

Detailed definition

The interest component of the lease liability for finance leases, calculated using the effective interest method. This r...

Peer comparison

Standard disclosure for companies with significant finance lease portfolios.

Metric ID: is_wmt_interest_expense_finance_leases

Historical Data

3 years
 FY'23FY'24FY'25
Value$38.80M$25.20M$5.70M
YoY Change—-35.1%-77.4%
Range$5.70M – $38.80M
CAGR-61.7%
Avg YoY Growth-56.2%
Median YoY Growth-56.2%
Current Streak2+ years decline

Frequently Asked Questions

What is Vertex Pharmaceuticals's finance lease interest?
Vertex Pharmaceuticals (VRTX) reported finance lease interest of $1.43M in Q4 2025.
How has Vertex Pharmaceuticals's finance lease interest changed year-over-year?
Vertex Pharmaceuticals's finance lease interest decreased by 77.4% year-over-year, from $6.30M to $1.43M.
What is the long-term trend for Vertex Pharmaceuticals's finance lease interest?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's finance lease interest has grown at a -61.7% compound annual growth rate (CAGR), from $38.80M to $5.70M.
What does finance lease interest mean?
The interest cost associated with finance lease obligations.